Trial Profile
Effects of Levosimendan on Diaphragm Function in Mechanically Ventilated Patients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Feb 2022
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Muscle weakness; Respiratory insufficiency
- Focus Therapeutic Use
- 01 Oct 2019 Status changed from recruiting to completed.
- 09 Jun 2015 Planned End Date changed from 1 Dec 2015 to 1 May 2016, according to to ClinicalTrials.gov record.
- 09 Jun 2015 Planned primary completion date changed from 1 Dec 2015 to 1 May 2016, according to to ClinicalTrials.gov record.